Regeneron Pharmaceuticals Inc (REGN)

Financial leverage ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total assets	US$ in thousands	37,759,400	33,080,200	29,214,500	25,434,800	17,163,300
Total stockholders’ equity	US$ in thousands	29,353,600	25,973,100	22,664,000	18,768,800	11,025,300
Financial leverage ratio		1.29	1.27	1.29	1.36	1.56

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $37,759,400K ÷ $29,353,600K
= 1.29

The financial leverage ratio of Regeneron Pharmaceuticals Inc has shown a decreasing trend over the past five years. Starting at 1.56 in December 2020, the ratio gradually declined to 1.29 by December 2022, experienced a slight drop to 1.27 by December 2023, and then remained stable at 1.29 by December 2024. This indicates that the company's reliance on debt to finance its operations has decreased over the period, which could be a positive sign of improved financial stability and lower financial risk. However, it is important to consider the overall industry trends and market conditions to assess the implications of this trend effectively.